347 results on '"Goyal, Vinod"'
Search Results
2. Physiological and Biochemical Underpinnings Drive Yield Enhancement in Indian Mustard (Brassica juncea) by Ortho Silicic Acid under Field Conditions
3. Comparative metabolome variation in Brassica juncea different organs from two varieties as analyzed using SPME and GCMS techniques coupled to chemometrics
4. Lymphoid tissues in toxicity studies: An over view
5. Bioequivalence, food effect and comparative pharmacokinetics of SUVN-1105, a novel granule formulation of abiraterone acetate, to Zytiga in healthy male subjects
6. Samelisant (SUVN-G3031), a histamine 3 receptor inverse agonist: Results from the phase 2 double-blind randomized placebo-controlled study for the treatment of excessive daytime sleepiness in adult patients with narcolepsy
7. Orthosilicic acid and Seaweed Extract Alleviate the Deteriorative Effects of High Temperature Stress in Brassica juncea (L.) Czern & Coss.
8. Rodents in Drug Discovery
9. The nematicidal potential of novel fungus, Trichoderma asperellum FbMi6 against Meloidogyne incognita
10. Survival mechanisms of chickpea (Cicer arietinum) under saline conditions
11. Alleviating Drought Stress in Brassica juncea (L.) Czern & Coss. by Foliar Application of Biostimulants—Orthosilicic Acid and Seaweed Extract
12. Effect of Concurrent Use of Memantine on the Efficacy of Masupirdine (SUVN-502): A Post Hoc Analysis of a Phase 2 Randomized Placebo-Controlled Study
13. Climate Change Impact on Alteration of Plant Traits
14. Niger (Guizotia Abyssinica (L. f.) Cass.) an Oilseed Crop under Biotic Stress
15. Amelioration Effect of Salicylic Acid Under Salt Stress in Sorghum bicolor L.
16. Safety, Tolerability, and Pharmacokinetics of Ropanicant (SUVN-911), a Novel Alpha4 Beta2 Nicotinic Acetylcholine Receptor (α4β2 nAChR) Antagonist, in Healthy Adult and Elderly Subjects
17. Ropanicant (SUVN-911), an α4β2 nicotinic acetylcholine receptor antagonist intended for the treatment of depressive disorders: pharmacological, behavioral, and neurochemical characterization
18. Analysis of salinity‐induced metabolome changes in Indian mustard (Brassica juncea) roots and shoots: hydroponic versus microplot cultivation.
19. Hits and misses with animal models of narcolepsy and the implications for drug discovery
20. First-in-Human Studies to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Novel 5-HT4 Partial Agonist, SUVN-D4010, in Healthy Adult and Elderly Subjects
21. Correction to: Alleviating Drought Stress in Brassica juncea (L.) Czern and Coss. by Foliar Application of Biostimulants—Orthosilicic Acid and Seaweed Extract
22. Safety, Tolerability, and Pharmacokinetics of SUVN-G3031, a Novel Histamine-3 Receptor Inverse Agonist for the Treatment of Narcolepsy, in Healthy Human Subjects Following Single and Multiple Oral Doses
23. Orthosilicic acid (OSA) reduced grain arsenic accumulation and enhanced yield by modulating the level of trace element, antioxidants, and thiols in rice
24. Economic Utilization and Potential of Halophytes
25. Oxidative Stress and Antioxidant Defence Under Metal Toxicity in Halophytes
26. Promoting Sustainable Agriculture: Approaches for Mitigating Soil Salinity Challenges: A ReviewPromoting Sustainable Agriculture: Approaches for Mitigating Soil Salinity Challenges: A Review
27. Masupirdine (SUVN‐502) for the Potential Treatment of Agitation in Patients with Dementia of the Alzheimer’s Type: Preliminary Efficacy and Phase‐3 Study Design
28. Correction to: Amelioration Effect of Salicylic Acid Under Salt Stress in Sorghum bicolor L.
29. Nanoscale CuO charge and morphology control Fusarium suppression and nutrient biofortification in field-grown tomato and watermelon
30. Assessment of toxicity and tolerability of a combination vehicle; 5% Pharmasolve, 45% Propylene glycol and 50% Polyethylene glycol 400 in rats following repeated intravenous administration
31. Green Synthesis and Characterization of Ginger-Derived Silver Nanoparticles and Evaluation of Their Antioxidant, Antibacterial, and Anticancer Activities.
32. Safety, Tolerability and Pharmacokinetics of the Serotonin 5-HT6 Receptor Antagonist, SUVN-502, in Healthy Young Adults and Elderly Subjects
33. 0609 Samelisant, Histamine 3 Receptor Agonist for the Potential Treatment of Excessive Daytime Sleepiness in Patients with Narcolepsy
34. Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease
35. Assessment of genetic variability, diversity, and identification of promising lines in linseed germplasm for harnessing genetic gain in central plain of the Indian subcontinent
36. Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders
37. Pinpointing Genomic Regions and Candidate Genes Associated with Seed Oil and Protein Content in Soybean through an Integrative Transcriptomic and QTL Meta-Analysis
38. Effects of Masupirdine (SUVN‐502) on Agitation/Aggression and Psychosis in Patients with Probable Alzheimer’s Disease: A Post Hoc Analysis
39. Effect of Concurrent Use of Memantine on The Efficacy of Masupirdine (SUVN‐502): A Post‐hoc Analysis of a Phase‐2 Randomized Placebo‐Controlled Study
40. Repetitive Sequences in Plant Nuclear DNA: Types, Distribution, Evolution and Function
41. Unlocking the Potential of Nano-Enabled Precision Agriculture for Efficient and Sustainable Farming.
42. Potential beneficial effects of masupirdine (SUVN‐502) on agitation/aggression and psychosis in patients with moderate Alzheimer's disease: Exploratory post hoc analyses
43. Retinal vein occlusion in COVID-19: A novel entity
44. 0624 Samelisant (SUVN-G3031), Baseline Characteristics from a Phase-2 Study Evaluating Efficacy and Safety in Patients with Narcolepsy
45. Samelisant (SUVN-G3031), a Histamine-3(H3) Receptor Inverse Agonist in Animal Models of Sleep Disorders (P1-1.Virtual)
46. Agrobacterium-Mediated Alien Gene Transfer Biofabricates Designer Plants
47. Contributors
48. Effect of masupirdine (SUVN‐502) on cognition in patients with moderate Alzheimer's disease: A randomized, double‐blind, phase 2, proof‐of‐concept study
49. Effect of Age, Cognitive Impairment Severity, and Duration of Disease on Efficacy of Masupirdine in Moderate Alzheimer's Disease Patients: A Post Hoc Analysis of a Phase-2 Randomized Placebo Controlled Study Results
50. Masupirdine (SUVN‐502): A promising clinical candidate for the management of agitation in Alzheimer’s dementia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.